NCT05440084

Brief Summary

Heart disease is a leading cause of death in the US. . Heart blood vessel chronic total occlusions are 100% blockages of the heart vessels. These patients often suffer from chest pain, shortness of breath, and depression. Heart doctors thread special cables from the groin and wrist to the heart and open up these 100% blocked vessels. . This treatment improves symptoms and quality of life. Exercise is very beneficial for health. Previous studies suggest that even a 1000 steps/day increase in daily steps can improve health. But, patients with occluded heart vessels are often inactive because they have chest pain, feeling tired, or are short of breath. It is unknown whether opening these 100% blocked heart vessels will help patients have a more active lifestyle, which is good for health. The goal is to measure the impact of opening these occluded heart vessels on daily exercise in this project. Specifically, the investigators will give a smart watch to patients referred for this treatment. The smart watch will track the patients' daily steps before and after the procedure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 30, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

June 27, 2022

Last Update Submit

January 22, 2025

Conditions

Keywords

Physical ActivityCTOPCIQuality of LifePercutaneous Coronary Intervention

Outcome Measures

Primary Outcomes (1)

  • Change in daily steps compared with baseline

    Significant change in daily steps at 3-month follow-up (as measured by smart watch)

    3 Months

Secondary Outcomes (2)

  • Change in calorie expenditure

    3 Months

  • Change in Seattle Angina Questionnaire-7 (SAQ-7) summary score follow-up compared with baseline

    3 months

Other Outcomes (1)

  • Change in Patient Health Questionnaire-8 (PHQ-8) depression score

    3 Months

Study Arms (1)

Patients referred for CTO PCI

Procedure: Chronic total occlusion percutaneous coronary intervention

Interventions

Chronic total occlusion percutaneous coronary intervention

Patients referred for CTO PCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred for CTO PCI at Minneapolis Heart Institute

You may qualify if:

  • Age 18 years or older
  • Willing and able to provide informed consent
  • Patients referred for clinically indicated CTO-PCI
  • Access to smart phone (Apple or Android platform)
  • Willing and able to wear a smart watch
  • Clinically stable and able to walk/ exercise independently

You may not qualify if:

  • Inability to exercise due to non-cardiac problems (e.g., orthopedic restrictions, amputation, musculoskeletal/neurological disease affecting mobility etc.-as determined by investigator discretion)
  • Plan for major surgical procedure (other than CTO PCI) which would limit exercise capability
  • Any other criteria that in the opinion of the investigator would preclude patient participation in the study and/or impact exercise capability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, 55407, United States

Location

MeSH Terms

Conditions

Bites and StingsMotor Activity

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and InjuriesBehavior

Study Officials

  • Emmanouil Brilakis, MD, PhD

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2022

First Posted

June 30, 2022

Study Start

September 1, 2022

Primary Completion

September 1, 2023

Study Completion

September 1, 2024

Last Updated

January 24, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations